R.PR
REGISTERED-PRINCIPAL REGISTER
11/30/2021
Back to search
Official data from USPTO
THE RIGHT MEDICATION THE FIRST TIME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE RIGHT MEDICATION THE FIRST TIME
ST13
US500000088863733Class
44
Filing
88863733
Registration
6577342
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
11/30/2021
Trademark type
Word
Nice classes
44
Filing date
04/08/2020
Registration date
11/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/30/2021
Last transaction
11/30/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2019-10-00
First use in commerce
2019-10-00
Drawing code
4
Owner type
16
Owner location
The Colony, TX, US
Examiner
DIBLE, JONATHON I
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GeneIQ, LLC
Representatives
Danica L. Mathes BELL NUNNALLY & MARTIN LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical and clinical testing for diagnostic or treatment purposes; genetic testing for medical purposes; pharmacogenomics testing for medical purposes; medical testing for diagnostic or treatment purposesfor customization of prescriptions and dosages; providing medical information to patients and physicianspharmacistsother healthcare professionals in the form of pharmacogentic dataanalysis and reportsreports in the field of pharmacogeneticspharmacogenomicsdrug-gene interactions as well as drug-drug-gene interactions; molecular testing for cancer and for respiratory drug-gene interactionsfor medical purposes
Publications
History of USPTO decisions and trademark events.
23 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/23/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/22/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/22/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/20/2021
IUAF
USE AMENDMENT FILED
10/06/2021
EISU
TEAS STATEMENT OF USE RECEIVED
10/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/03/2021
EX1G
SOU EXTENSION 1 GRANTED
04/01/2021
EXT1
SOU EXTENSION 1 FILED
04/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2020
PUBO
PUBLISHED FOR OPPOSITION
08/11/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/06/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
07/06/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/06/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
07/06/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/06/2020
DOCK
ASSIGNED TO EXAMINER
06/26/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/15/2020
NWAP
NEW APPLICATION ENTERED
04/11/2020
Continuous trademark protection
Get notified about every new filing that threatens THE RIGHT MEDICATION THE FIRST TIME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.